Rituximab-mediated release of CLL cells from lymph nodes to periphery: use of CD62L molecule as a marker.

Borský,  Marek; Novotná,  Jitka; Brychtová,  Yvona; Doubek,  Michael; Mayer,  Jiří; Trbušek,  Martin

Rituximab-mediated release of CLL cells from lymph nodes to periphery: use of CD62L molecule as a marker.

Warning

This publication doesn't include Institute of Computer Science. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Authors	BORSKÝ Marek NOVOTNÁ Jitka BRYCHTOVÁ Yvona DOUBEK Michael MAYER Jiří TRBUŠEK Martin
Year of publication	2017
Type	Conference abstract
MU Faculty or unit	Faculty of Medicine
Citation
Description	Rituximab-mediated release of CLL cells from lymph nodes to periphery: use of CD62L molecule as a marker, Rituximab-mediated release of CLL cells from lymph nodes to periphery: use of CD62L molecule as a marker.
Related projects:	Predictive stratification of CLL patients for therapy involving monoclonal antibodies targeting CD20